Boehringer OKs $100M biobucks deal for hearing loss R&D project

Boehringer Ingelheim has come sweeping down into Oklahoma to land rights to a treatment for the most common type of permanent hearing loss, joining up with Autigen in a $100 million biobucks deal to work on a drug that restores sensory hair cells.